Fuente: WIPO "biotechnology" The present invention is in the fields of medicine, vaccine and pharmaceutical formulation. The invention provides formulations comprising an angiotensin-virus-like particle conjugate and a stabilizer, wherein said stabilizer comprises a non-reducing disaccharide and a non-ionic surfactant. The lyophilized formulations are stable after a long time of storage at room temperature.